caplacizumab-yhdp 11 MG Injection

RxCUI: 2110616
RxNorm name: caplacizumab-yhdp 11 MG Injection
Display name: caplacizumab-yhdp 11 MG Injection
Full name: caplacizumab-yhdp 11 MG Injection
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:50

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761112	Cablivi	caplacizumab-yhdp	351(a)	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cablivi	CAPLACIZUMAB	Genzyme Corporation	2348f06e-8004-4040-832e-e9e86a39f905	2026-04-24	Warnings, Adverse reactions	Exact identifier rxcui: 2110616

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
2348f06e-8004-4040-832e-e9e86a39f905	caplacizumab-yhdp 11 MG Injection [PSN] · caplacizumab-yhdp 11 MG Injection [SCD]	2	18	These highlights do not include all the information needed to use CABLIVI ® safely and effectively. See full prescribing information for CABLIVI. CABLIVI (caplacizumab-yhdp) for injection, for intravenous or subcutaneous use Initial U.S. Approval: 2019	20260424